|
|
U.S. Artificial Heart Valve MarketsPublished by: Frost & Sullivan Published: Nov. 30, 2006 Table of Contents1. Executive Summary 1. Executive Summary 1. Executive Summary 2. U.S. Artificial Heart Valves Market 1. Market Overview 1. Overview 2. Scope and Segmentation 2. Market Trends 1. Market Drivers a. Increased Device Durability Spurs Confidence in Device Usage b. Lack of Effective Pharmaceutical or other Non-invasive Treatment for Heart Valve Disease Heightens Demand for Interventional Devices c. Advances in Polymer Technology Augment Biomimetic Device Performance d. Increased Screening and Diagnosis Expand Patient Population 2. Market Restraints a. Saturated Patient Population Limits Market Potential for Growth b. Price Stagnation Inhibits Market 3. Challenges and Strategies 1. Industry Challenges 2. Strategies 4. Market Forecasts and Analysis 1. Market Engineering Measurements 2. Total Revenue Forecasts 3. Total Heart Valve Replacement Procedures 4. Procedural Volume by Valve Type 5. Competitive Analysis 1. Competitive Structure 2. Competitive Factors 3. Distribution Structure 4. Key End-user Group 5. Market Share Analysis 6. Technology and Market Trends 1. Emerging Technologies 2. Mergers and Acquisitions 3. Start-up Market Activity 4. Reimbursement Trends 5. Regulatory Trends 3. Tissue Valve Replacement Market 1. Market Forecast and Analysis 1. Market Overview 2. Market Engineering Measurements 3. Revenue Forecasts 4. Procedure Forecasts 2. Competitive Analysis 1. Market Share Analysis 2. Product Chart 4. Mechanical Valve Replacement Market 1. Market Forecast and Analysis 1. Market Overview 2. Market Engineering Measurements 3. Revenue Forecasts 4. Procedure Forecasts 2. Competitive Analysis 1. Market Share Analysis 2. Product Chart 5. Heart Valve Repair Products 1. Market Forecast and Analysis 1. Market Overview 2. Market Engineering Measurements 3. Revenue Forecasts 2. Competitive Analysis 1. Market Share Analysis 2. Product Chart 6. Decision Support Databases 1. Decision Support Databases 1. Population 65 and above 2. Obesity Rates 3. Hospitals 4. Cardiovascular Mortality 5. Cardiologists 6. Cerebrovascular Mortality 7. Cerbrovasular Hospital Discharge List of Figures Chapter 2
Chapter 3
Chapter 4
Chapter 5
AbstractResearch OverviewThe Frost & Sullivan research service titled U.S. Artificial Heart Valve Markets provides an overview of the trends and technologies that have shaped market revenues, market share, and implantation rates in the individual segments of the market. In this research service, Frost & Sullivan's expert analysts thoroughly examine the following markets: tissue replacement valves, mechanical replacement valves, and heart valve repair products. Market Sectors Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
The following technologies are covered in this research service:
Increased Device Durability Spurring Confidence in New Bioprosthetic Replacement Heart Valves The cardiovascular system is one of the most complicated systems in the human body. It requires the coordination of a number of muscles, valves, and nerves to ensure consistent and constant blood flow. Any disruption or malfunction in the process, could lead to death within minutes. A key mechanism in that process is the functionality of the small tissue valves located in each of the four chambers of the heart. These small tissue flaps serve as one way gates to control flow of blood, and ensure no reverse leakage. When these tissue flaps become diseased, they can create major problems for cardiovascular function. If the diseased valve is weakened, creating a gap, there is a regurgitation of flow. On the opposite end of the spectrum, if the valve undergoes stenosis, the narrowed valve opening forces the heart to exert more force, and thereby stress to maintain blood flow. Most of these conditions develop over time, and when diagnosed require immediate attention. Due to a lack of significant pharmaceutical therapies that can reverse valvular disease, primary intervention is the gold standard for care. When a defect is detected, a specialist must make the decision if the valve can be repaired, or it needs to be replaced. Heart valve repair with annuloplasty involves the stitching of a ring at the base of the valve in order to help it maintain a level of tightness. If repair is too risky or the valve is beyond repair, the valve is replaced outright with an artificial valve. Artificial heart replacement valves have been in existence since the 1950’s. While there have been significant upgrades in the materials used and methodology of implantation for these devices, currently used devices are essentially analogous to the first generation of devices developed fifty years ago. Surgeons must weigh the options between selecting a mechanical tissue valve, or one made of animal tissue. The issues of selecting one over the other are the same trade off that has existed since their inception. Mechanical valves are more durable, while tissue valves are more biocompatible. As the societal demographic shifts towards an older and more obese population, there is a heightened demand for advanced heart valve therapy products. Market Dedicating Focus to Design of Percutaneous Products Endovascular surgeries are becoming the preferred approach for treating cardiovascular diseases. Being able to insert a catheter in a peripheral blood vessel, and perform a surgery anywhere in the body has immense appeal to surgeons. They have become well versed in the techniques and tools involved for minimally invasive procedures, and see an immense benefit over open cavity approaches. Therefore, with respect to replacement heart valve implantation and heart valve repair, clinicians are looking to manufacturers that can provide them the most advanced minimally invasive solutions. Since each device has its own specifics for operation, once a provider trains himself on a certain product it becomes increasingly more difficult to convert them to a competitor’s device. Therefore, it is important that manufacturers keep pace with competitors and introduce the latest in percutaneous products, or else sacrifice future sales as a late arriver. Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||